India Mulls Risk-Based Pre-Inspections to Address Substandard Drugs

International Pharmaceutical Regulatory Monitor
A A
India’s Ministry of Health is proposing that drug regulators and drugmakers implement several measures to improve the quality of drugs in the country’s supply chain, following a government estimate that 10 percent of them are substandard.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor